HCA

HCA Healthcare, Inc. Healthcare - Medical Care Facilities Investor Relations →

NO
41.9% ABOVE
↑ Moving away Was 41.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $351.79
14-Week RSI 75
Rel. Volume (14w) This week's trading vs. the 14-week average 0.9x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.27

HCA Healthcare, Inc. (HCA) closed at $499.05 as of 2026-11-13, trading 41.9% above its 200-week moving average of $351.79. The stock moved further from the line this week, up from 41.2% last week. With a 14-week RSI of 75, HCA is in overbought territory.

Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.27 ratio) is neutral — neither side is clearly dominating.

Over the past 770 weeks of data, HCA has crossed below its 200-week moving average 5 times. On average, these episodes lasted 3 weeks. Historically, investors who bought HCA at the start of these episodes saw an average one-year return of +108.3%.

With a market cap of $104.2 billion, HCA is a large-cap stock. The company generates a free cash flow yield of 3.8%. The stock trades at -13.0x book value.

The company has been aggressively buying back shares, reducing its share count by 19.0% over the past three years.

Over the past 14.8 years, a hypothetical investment of $100 in HCA would have grown to $2409, compared to $710 for the S&P 500. That represents an annualized return of 23.9% vs 14.1% for the index — confirming HCA as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 23.1% compound annual rate, with 4 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: HCA vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After HCA Crosses Below the Line?

Across 5 historical episodes, buying HCA when it crossed below its 200-week moving average produced an average return of +104.8% after 12 months (median +101.0%), compared to +35.6% for the S&P 500 over the same periods. 100% of those episodes were profitable after one year. After 24 months, the average return was +134.4% vs +47.6% for the index.

Each line shows $100 invested at the moment HCA crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices HCA would reach each dislocation threshold.

Current Bean Score -1.77σ
Current FCF Yield 5.73%
Baseline Yield 6.70%
Historical σ 0.43pp

Dislocation Price Levels

Prices where HCA's Bean Score would hit each σ threshold. Valid until next earnings report: 2027-01-26.

LevelσPriceSignal
Deep Value+2σ$389.50Unusually cheap — analysis point
Value+1σ$413.56Cheap vs. own history
Fair Value+0σ$440.78Historical mean behavior
Expensive-1σ$471.83Expensive vs. own history
Deep Expensive-2σ$507.60Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-27$6.63$7.22+8.9%
2026-07-24$7.50$7.59+1.2%
2026-04-24$7.13$7.15+0.3%
2026-01-27$7.48$8.01+7.1%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from HCA's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation -0.38σ Dividend yield vs own 10-yr norm
Drawdown Score +0.02σ Distance from line vs own history
Sector-Relative -0.12σ Vs sector median this week
Buyback Acceleration -3.4pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History -3.2pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (-1.7pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

HCA has crossed below its 200-week MA 5 times with an average 1-year return of +108.3% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Mar 2012Apr 201211.1%+89.9%+2422.8%
May 2012Jun 201232.2%+83.5%+2434.1%
Mar 2020Apr 2020324.3%+141.4%+568.9%
May 2020May 202015.7%+115.2%+431.7%
Jun 2020Jul 2020512.4%+111.5%+422.2%
Average3—+108.3%—

Frequently Asked Questions

Is HCA below its 200-week moving average?

No. HCA Healthcare, Inc. (HCA) is currently 41.9% above its 200-week moving average of $351.79. It would need to fall to $351.79 to cross below the line.

What is HCA's 200-week moving average price?

HCA Healthcare, Inc.'s 200-week moving average is $351.79 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when HCA drops below its 200-week moving average?

HCA has crossed below its 200-week moving average 5 times in our data. On average, buying at that moment produced a one-year return of +108.3%. These dips have historically been decent entry points. These episodes lasted 3 weeks on average.

Is HCA a good value right now?

Here's what our data says about HCA as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 75 (overbought). Free cash flow yield is 3.8%. Price-to-book is -13.0x. This is not a buy or sell recommendation — always do your own research.

How does HCA compare to the S&P 500?

Over the past 14.8 years, $100 invested in HCA would have grown to $2409, compared to $710 for the S&P 500. That's 23.9% annualized vs 14.1% for the index. HCA has outperformed the broader market over this period.

Does HCA pay a dividend?

Yes. HCA Healthcare, Inc. currently pays a dividend yield of 63.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13